EXHIBIT 32.1


          CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 (AS ADOPTED
                         PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002)

         In connection with the quarterly report of Stellar Pharmaceuticals Inc.
(the "Company") on Form 10-QSB for the quarter ended March 31, 2008 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Peter Riehl, Chief Executive Officer, certify to my knowledge and in my
capacity as an officer of the Company, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

            1.    The Report fully complies with the requirements of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934, as
                  amended; and,

            2.    The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company as of the dates and for the periods
                  expressed in the Report.

Date:  May 15, 2008

                                          /s/ Peter Riehl
                                          --------------------------------------
                                          Peter Riehl
                                          President and Chief Executive Officer